Body Protect Compound

$149.99
Thumbnail for Body Protect Compound Healthgevity - Conners Clinic Thumbnail for Body Protect Compound Healthgevity - Conners Clinic Thumbnail for Body Protect Compound Healthgevity - Conners Clinic
Body Protect Compound Healthgevity - Conners Clinic
Body Protect Compound Healthgevity - Conners Clinic
Body Protect Compound Healthgevity - Conners Clinic

Products usually ship out within 3-7 business days

Body Protect Compound

$149.99
0 have this item in their cart.
Description of Body Protect Compound

BPC-157 is a pentadecapeptide made up of 15 amino acids that is derived from human gastric juice. It has a molecular weight of 2212 daltons and its sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is also known as the “Wolverine” peptide, for its ability to help support repair and recovery, many have also found that it’s helped support gut issues, gastric reflux, depression, performance, and more. 

BPC-157 has been studied for a variety of topics and has shown to be helpful in many areas such as: tendinopathy, gastric ulcers, general inflammation, and even neuroprotection. BPC-157 seems to work by interacting with our cells’ systems that are responsible for growth and repair, thus helping the body to heal itself.

One of the most exciting potential benefits of BPC-157 is its ability to help with tendon repair. Tendons are the tough, fibrous tissues that connect our muscles to our bones and are essential for movement. However, tendons are also susceptible to injury and can often be slow to heal. This is where BPC-157 comes in; by aiding in the repair and regeneration of damaged tendons, BPC-157 could potentially help reduce recovery time and improve outcomes following an injury.

BPC-157 has also been shown to be beneficial in supporting the healing of gastric ulcers. Gastric ulcers are a type of peptic ulcer that develops in the lining of the stomach. They are a common and often painful condition that can be difficult to treat. However, BPC-157 has been shown to promote healing of gastric ulcers and improve symptoms.

There is also some evidence to suggest that BPC-157 may be helpful in supporting inflammatory bowel disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract. Symptoms can include abdominal pain, diarrhea, and weight loss. BPC-157 has been shown to reduce inflammation and improve symptoms in animal models of IBD. Overall, BPC-157 appears to be a promising compound with the potential to support a variety of gastrointestinal disorders. 

One of the best things about BPC-157 is that it is orally bioavailable, particularly the arginate salt we use, is extremely stable.   We wanted to make sure that oral bioavailability was maximized which is why we included a molecule called SNAC in our formulation.

Salcaprozate sodium, or SNAC, is one of the most advanced intestinal permeation enhancers that have been tested in clinical trials for oral delivery of macromolecules. It was originally designed for the oral delivery of insulin. In one study, SNAC increased the absorption of a peptide (a short chain of amino acids) by nine-fold without affecting tight junctions. 

Healthgevity's formulation includes an optimal ratio of salcaprozate sodium to our active ingredients. This combination results in exceptional oral absorption of this combination without compromising its stability or efficacy.

*This item may take longer to ship out*

REFERENCES

BPC-157:

  • Staresinic M, Japjec M, Vranes H, Prtoric A, Zizek H, Krezic I, Gojkovic S, Smoday IM, Oroz K, Staresinic E, Dretar V, Yago H, Milavic M, Sikiric S, Lovric E, Batelja Vuletic L, Simeon P, Dobric I, Strbe S, Kokot A, Vlainic J, Blagaic AB, Skrtic A, Seiwerth S, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. Biomedicines. 2022; 10(12):3221. https://doi.org/10.3390/biomedicines10123221
  • Seiwerth, Sven et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” Current pharmaceutical design vol. 24,18 (2018): 1972-1989. doi:10.2174/1381612824666180712110447
  • Gwyer, Daniel et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and tissue research vol. 377,2 (2019): 153-159. doi:10.1007/s00441-019-03016-8
  • Chang, Chung-Hsun et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of applied physiology (Bethesda, Md. : 1985) vol. 110,3 (2011): 774-80. doi:10.1152/japplphysiol.00945.2010
  • Sikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current neuropharmacology vol. 14,8 (2016): 857-865. doi:10.2174/1570159x13666160502153022
  •  Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki, M., Ljubanovic, D., … Kolega, Z. (1997). BPC 157’s effect on Healing. Journal of Physiology Paris, 91(3–5), 173–178. https://doi.org/10.1016/S0928-4257(97)89480-6

Salcaprozate sodium (SNAC):

  • Twarog, Caroline et al. “Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10).” Pharmaceutics vol. 11,2 78. 13 Feb. 2019, doi:10.3390/pharmaceutics11020078
  • Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016/j.apsb.2021.04.001. Epub 2021 Apr 29. PMID: 34522593; PMCID: PMC8424290.
  • Aroda, V.R., Blonde, L. & Pratley, R.E. A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Rev Endocr Metab Disord 23, 979–994 (2022). https://doi.org/10.1007/s11154-022-09735-8

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
{"id":8516441374940,"title":"Body Protect Compound","handle":"body-protect-compound","description":"\u003cdiv class=\"product-single__description rte\"\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 is a pentadecapeptide made up of 15 amino acids that is derived from human gastric juice. It has a molecular weight of 2212 daltons and its sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is also known as the “Wolverine” peptide, for its ability to help support repair and recovery, many have also found that it’s helped support gut issues, gastric reflux, depression, performance, and more. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 has been studied for a variety of topics and has shown to be helpful in many areas such as: tendinopathy, gastric ulcers, general inflammation, and even neuroprotection. BPC-157 seems to work by interacting with our cells’ systems that are responsible for growth and repair, thus helping the body to heal itself.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eOne of the most exciting potential benefits of BPC-157 is its ability to help with tendon repair. Tendons are the tough, fibrous tissues that connect our muscles to our bones and are essential for movement. However, tendons are also susceptible to injury and can often be slow to heal. This is where BPC-157 comes in; by aiding in the repair and regeneration of damaged tendons, BPC-157 could potentially help reduce recovery time and improve outcomes following an injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 has also been shown to be beneficial in supporting the healing of gastric ulcers. Gastric ulcers are a type of peptic ulcer that develops in the lining of the stomach. They are a common and often painful condition that can be difficult to treat. However, BPC-157 has been shown to promote healing of gastric ulcers and improve symptoms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eThere is also some evidence to suggest that BPC-157 may be helpful in supporting inflammatory bowel disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract. Symptoms can include abdominal pain, diarrhea, and weight loss. BPC-157 has been shown to reduce inflammation and improve symptoms in animal models of IBD. Overall, BPC-157 appears to be a promising compound with the potential to support a variety of gastrointestinal disorders. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eOne of the best things about BPC-157 is that it is orally bioavailable, particularly the arginate salt we use, is extremely stable.   We wanted to make sure that oral bioavailability was maximized which is why we included a molecule called SNAC in our formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSalcaprozate sodium, or SNAC\u003c\/b\u003e\u003cspan style=\"font-weight: 400;\"\u003e, is one of the most advanced intestinal permeation enhancers that have been tested in clinical trials for oral delivery of macromolecules. It was originally designed for the oral delivery of insulin. In one study, SNAC increased the absorption of a peptide (a short chain of amino acids) by nine-fold without affecting tight junctions. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eHealthgevity's formulation includes an optimal ratio of salcaprozate sodium to our active ingredients. This combination results in exceptional oral absorption of this combination without compromising its stability or efficacy.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e*This item may take longer to ship out*\u003c\/span\u003e\u003c\/h3\u003e\n\u003cheader class=\"section-header\"\u003e\n\u003ch1 class=\"section-header__title\"\u003eREFERENCES\u003c\/h1\u003e\n\u003c\/header\u003e\n\u003cdiv class=\"rte rte--nomargin\"\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003eStaresinic M, Japjec M, Vranes H, Prtoric A, Zizek H, Krezic I, Gojkovic S, Smoday IM, Oroz K, Staresinic E, Dretar V, Yago H, Milavic M, Sikiric S, Lovric E, Batelja Vuletic L, Simeon P, Dobric I, Strbe S, Kokot A, Vlainic J, Blagaic AB, Skrtic A, Seiwerth S, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. \u003c\/span\u003e\u003cem\u003eBiomedicines\u003c\/em\u003e\u003cspan\u003e. 2022; 10(12):3221. https:\/\/doi.org\/10.3390\/biomedicines10123221\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eSeiwerth, Sven et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCurrent pharmaceutical design\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 24,18 (2018): 1972-1989. doi:10.2174\/1381612824666180712110447\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eGwyer, Daniel et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCell and tissue research\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 377,2 (2019): 153-159. doi:10.1007\/s00441-019-03016-8\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eChang, Chung-Hsun et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eJournal of applied physiology (Bethesda, Md. : 1985)\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 110,3 (2011): 774-80. doi:10.1152\/japplphysiol.00945.2010\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eSikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCurrent neuropharmacology\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 14,8 (2016): 857-865. doi:10.2174\/1570159x13666160502153022\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003e Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki, M., Ljubanovic, D., … Kolega, Z. (1997). \u003c\/span\u003e\u003cspan\u003eBPC 157’s effect on Healing.\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eJournal of Physiology Paris\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e, \u003c\/span\u003e\u003ci\u003e\u003cspan\u003e91\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e(3–5), 173–178. \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0928-4257(97)89480-6\"\u003e\u003cspan\u003ehttps:\/\/doi.org\/10.1016\/S0928-4257(97)89480-6\u003c\/span\u003e\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSalcaprozate sodium (SNAC):\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003eTwarog, Caroline et al. “Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C\u003c\/span\u003e\u003cspan\u003e10\u003c\/span\u003e\u003cspan\u003e).” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003ePharmaceutics\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 11,2 78. 13 Feb. 2019, doi:10.3390\/pharmaceutics11020078\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eZhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016\/j.apsb.2021.04.001. Epub 2021 Apr 29. PMID: 34522593; PMCID: PMC8424290.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAroda, V.R., Blonde, L. \u0026amp; Pratley, R.E. A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. \u003ci\u003eRev Endocr Metab Disord\u003c\/i\u003e \u003cb\u003e23\u003c\/b\u003e, 979–994 (2022). https:\/\/doi.org\/10.1007\/s11154-022-09735-8\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","published_at":"2024-04-30T10:11:37-05:00","created_at":"2024-04-30T10:11:37-05:00","vendor":"Healthgevity","type":"","tags":["Gut Health","Men","Women"],"price":14999,"price_min":14999,"price_max":14999,"available":true,"price_varies":false,"compare_at_price":null,"compare_at_price_min":0,"compare_at_price_max":0,"compare_at_price_varies":false,"variants":[{"id":45043961790684,"title":"Default Title","option1":"Default Title","option2":null,"option3":null,"sku":"","requires_shipping":true,"taxable":true,"featured_image":null,"available":true,"name":"Body Protect Compound","public_title":null,"options":["Default Title"],"price":14999,"weight":170,"compare_at_price":null,"inventory_management":"shopify","barcode":"","requires_selling_plan":false,"selling_plan_allocations":[],"quantity_rule":{"min":1,"max":null,"increment":1}}],"images":["\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472365039836.png?v=1729196294","\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323850460.png?v=1714490438","\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323817692.png?v=1714490438"],"featured_image":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472365039836.png?v=1729196294","options":["Title"],"media":[{"alt":"Body Protect Compound Healthgevity - Conners Clinic","id":33137624350940,"position":1,"preview_image":{"aspect_ratio":1.0,"height":614,"width":614,"src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472365039836.png?v=1729196294"},"aspect_ratio":1.0,"height":614,"media_type":"image","src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472365039836.png?v=1729196294","width":614},{"alt":"Body Protect Compound Healthgevity - Conners Clinic","id":33137588928732,"position":2,"preview_image":{"aspect_ratio":1.433,"height":443,"width":635,"src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323850460.png?v=1714490438"},"aspect_ratio":1.433,"height":443,"media_type":"image","src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323850460.png?v=1714490438","width":635},{"alt":"Body Protect Compound Healthgevity - Conners Clinic","id":33137589223644,"position":3,"preview_image":{"aspect_ratio":1.168,"height":530,"width":619,"src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323817692.png?v=1714490438"},"aspect_ratio":1.168,"height":530,"media_type":"image","src":"\/\/shop.connersclinic.com\/cdn\/shop\/files\/body-protect-compound-healthgevity-conners-clinic-40472323817692.png?v=1714490438","width":619}],"requires_selling_plan":false,"selling_plan_groups":[],"content":"\u003cdiv class=\"product-single__description rte\"\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 is a pentadecapeptide made up of 15 amino acids that is derived from human gastric juice. It has a molecular weight of 2212 daltons and its sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is also known as the “Wolverine” peptide, for its ability to help support repair and recovery, many have also found that it’s helped support gut issues, gastric reflux, depression, performance, and more. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 has been studied for a variety of topics and has shown to be helpful in many areas such as: tendinopathy, gastric ulcers, general inflammation, and even neuroprotection. BPC-157 seems to work by interacting with our cells’ systems that are responsible for growth and repair, thus helping the body to heal itself.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eOne of the most exciting potential benefits of BPC-157 is its ability to help with tendon repair. Tendons are the tough, fibrous tissues that connect our muscles to our bones and are essential for movement. However, tendons are also susceptible to injury and can often be slow to heal. This is where BPC-157 comes in; by aiding in the repair and regeneration of damaged tendons, BPC-157 could potentially help reduce recovery time and improve outcomes following an injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eBPC-157 has also been shown to be beneficial in supporting the healing of gastric ulcers. Gastric ulcers are a type of peptic ulcer that develops in the lining of the stomach. They are a common and often painful condition that can be difficult to treat. However, BPC-157 has been shown to promote healing of gastric ulcers and improve symptoms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eThere is also some evidence to suggest that BPC-157 may be helpful in supporting inflammatory bowel disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract. Symptoms can include abdominal pain, diarrhea, and weight loss. BPC-157 has been shown to reduce inflammation and improve symptoms in animal models of IBD. Overall, BPC-157 appears to be a promising compound with the potential to support a variety of gastrointestinal disorders. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eOne of the best things about BPC-157 is that it is orally bioavailable, particularly the arginate salt we use, is extremely stable.   We wanted to make sure that oral bioavailability was maximized which is why we included a molecule called SNAC in our formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSalcaprozate sodium, or SNAC\u003c\/b\u003e\u003cspan style=\"font-weight: 400;\"\u003e, is one of the most advanced intestinal permeation enhancers that have been tested in clinical trials for oral delivery of macromolecules. It was originally designed for the oral delivery of insulin. In one study, SNAC increased the absorption of a peptide (a short chain of amino acids) by nine-fold without affecting tight junctions. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eHealthgevity's formulation includes an optimal ratio of salcaprozate sodium to our active ingredients. This combination results in exceptional oral absorption of this combination without compromising its stability or efficacy.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e*This item may take longer to ship out*\u003c\/span\u003e\u003c\/h3\u003e\n\u003cheader class=\"section-header\"\u003e\n\u003ch1 class=\"section-header__title\"\u003eREFERENCES\u003c\/h1\u003e\n\u003c\/header\u003e\n\u003cdiv class=\"rte rte--nomargin\"\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003eStaresinic M, Japjec M, Vranes H, Prtoric A, Zizek H, Krezic I, Gojkovic S, Smoday IM, Oroz K, Staresinic E, Dretar V, Yago H, Milavic M, Sikiric S, Lovric E, Batelja Vuletic L, Simeon P, Dobric I, Strbe S, Kokot A, Vlainic J, Blagaic AB, Skrtic A, Seiwerth S, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. \u003c\/span\u003e\u003cem\u003eBiomedicines\u003c\/em\u003e\u003cspan\u003e. 2022; 10(12):3221. https:\/\/doi.org\/10.3390\/biomedicines10123221\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eSeiwerth, Sven et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCurrent pharmaceutical design\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 24,18 (2018): 1972-1989. doi:10.2174\/1381612824666180712110447\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eGwyer, Daniel et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCell and tissue research\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 377,2 (2019): 153-159. doi:10.1007\/s00441-019-03016-8\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eChang, Chung-Hsun et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eJournal of applied physiology (Bethesda, Md. : 1985)\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 110,3 (2011): 774-80. doi:10.1152\/japplphysiol.00945.2010\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eSikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eCurrent neuropharmacology\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 14,8 (2016): 857-865. doi:10.2174\/1570159x13666160502153022\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003e Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki, M., Ljubanovic, D., … Kolega, Z. (1997). \u003c\/span\u003e\u003cspan\u003eBPC 157’s effect on Healing.\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003ci\u003e\u003cspan\u003eJournal of Physiology Paris\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e, \u003c\/span\u003e\u003ci\u003e\u003cspan\u003e91\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e(3–5), 173–178. \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0928-4257(97)89480-6\"\u003e\u003cspan\u003ehttps:\/\/doi.org\/10.1016\/S0928-4257(97)89480-6\u003c\/span\u003e\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSalcaprozate sodium (SNAC):\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003eTwarog, Caroline et al. “Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C\u003c\/span\u003e\u003cspan\u003e10\u003c\/span\u003e\u003cspan\u003e).” \u003c\/span\u003e\u003ci\u003e\u003cspan\u003ePharmaceutics\u003c\/span\u003e\u003c\/i\u003e\u003cspan\u003e vol. 11,2 78. 13 Feb. 2019, doi:10.3390\/pharmaceutics11020078\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eZhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016\/j.apsb.2021.04.001. Epub 2021 Apr 29. PMID: 34522593; PMCID: PMC8424290.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAroda, V.R., Blonde, L. \u0026amp; Pratley, R.E. A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. \u003ci\u003eRev Endocr Metab Disord\u003c\/i\u003e \u003cb\u003e23\u003c\/b\u003e, 979–994 (2022). https:\/\/doi.org\/10.1007\/s11154-022-09735-8\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e"}

Used by Professionals

Hand-Selected by Dr. Kevin Conners

Fulfilled Locally in the USA

We are a Wisconsin-based family company

Trusted Source of Nutrition

We only carry the best products

©️ Conners Clinic uses Booster Theme

Visa Mastercard Discover American Express JCB Diners Club Apple Pay